Maintenance hormone therapy with letrozole after first-line chemotherapy in postmenopausal patients with hormone receptor-positive metastatic breast cancer

被引：0
作者：
Borrego, M. Ruiz
De la Haba, J.
Morales, S.
Ramos, M.
Velasco, A.
Mendez, M.
Carabantes, F.
Barnadas, A.
Garcia, M.
Moreno, J. A.
机构：
[1] Virgin Rocio Hosp, Dept Oncol, Seville, Spain
[2] Reina Sofia Hosp, Dept Oncol, Cordoba, Spain
[3] Arnau Vilanova Hosp, Lleida, Spain
[4] Oncol Ctr Galicia, Dept Oncol, La Coruna, Spain
[5] La Princesa Hosp, Dept Oncol, Madrid, Spain
[6] Mostoles Hosp, Dept Oncol, Mostoles, Spain
[7] Carlos Haya Hosp, Dept Oncol, Malaga, Spain
[8] Hosp Germans Trias & Pujol, Dept Oncol, Badalona, Spain
[9] Ciudad Real Hosp, Dept Oncol, Ciudad Real, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
[21]   First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients [J].
Liang, Xu ;
Yan, Ying ;
Wang, Lina ;
Song, Guohong ;
Di, Lijun ;
Jiang, Hanfang ;
Wang, Chaoying ;
Li, Huiping .
ONCOLOGY LETTERS, 2015, 9 (02) :987-993
[22]   Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer [J].
Lippman, Marc .
LANCET ONCOLOGY, 2019, 20 (03) :312-313
[23]   Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma [J].
Gluck, S .
CANCER, 2002, 95 (11) :2442-2443
[24]   Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study [J].
Yuan, Yang ;
Zhang, Shaohua ;
Yan, Min ;
Yin, Yongmei ;
Song, Yuhua ;
Jiang, Zefei .
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
[25]   Fulvestrant as maintenance therapy after first-line chemotherapy in postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer patients (FANCY): A prospective, multicenter, single arm phase II study. [J].
Wang, Shusen ;
Xu, Fei ;
Ouyang, Quchang ;
Yuan, Zhongyu ;
Pang, Danmei ;
Yuan, Huimin ;
Peng, Roujun ;
Xia, Wen ;
Zheng, Qiufan .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[26]   Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer [J].
Johnston, Stephen R. D. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) :89-102
[27]   Phase I/II study of letrozole and sorafenib as first-line therapy of hormone-receptor positive (HR plus ) metastatic breast cancer (MBC). [J].
Tan, Antoinette R. ;
Wong, Serena Tsan-Lai ;
Warren, Robert D. ;
Eng-Wong, Jennifer ;
Liu, Minetta C. ;
Zelnak, Amelia Bruce ;
Lin, Yong ;
Shih, Weichung ;
Ganesan, Shridar ;
Grana, Generosa ;
Isaacs, Claudine ;
Toppmeyer, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[28]   Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy [J].
Alessandra Fabi ;
Michelangelo Russillo ;
Gianluigi Ferretti ;
Giulio Metro ;
Cecilia Nisticò ;
Paola Papaldo ;
Ferdinando De Vita ;
Giuliana D’Auria ;
Antonello Vidiri ;
Diana Giannarelli ;
Francesco Cognetti .
BMC Cancer, 12
[29]   Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy [J].
Fabi, Alessandra ;
Russillo, Michelangelo ;
Ferretti, Gianluigi ;
Metro, Giulio ;
Nistico, Cecilia ;
Papaldo, Paola ;
De Vita, Ferdinando ;
D'Auria, Giuliana ;
Vidiri, Antonello ;
Giannarelli, Diana ;
Cognetti, Francesco .
BMC CANCER, 2012, 12
[30]   Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer [J].
Yuan, Yuan ;
Lee, Jin Sun ;
Yost, Susan E. ;
Frankel, Paul H. ;
Ruel, Christopher ;
Egelston, Colt A. ;
Guo, Weihua ;
Padam, Simran ;
Tang, Aileen ;
Martinez, Norma ;
Schmolze, Daniel ;
Presant, Cary ;
Ebrahimi, Behnam ;
Yeon, Christina ;
Sedrak, Mina ;
Patel, Niki ;
Portnow, Jana ;
Lee, Peter ;
Mortimer, Joanne .
EUROPEAN JOURNAL OF CANCER, 2021, 154 :11-20
12345